'Coronary intervention' diaporamas de présentation

Management of Coronary Artery Disease

734 views • 58 slides

UK Trial Update

UK Trial Update. Simon Redwood Advanced Angioplasty Jan 2006. No Conflict of Interest. BCIS-1 Study B alloon-pump assisted C oronary I ntervention S tudy . A British Cardiovascular Intervention Society Project. p=0.29. p=0.001. IABP use during high-risk PCI. n=133, elective PCI

351 views • 22 slides

Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov

Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function. Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov. Case Overview. Patient is a 55-year old male with a history of stable ischemic heart disease.

338 views • 21 slides

Reducing Readmissions

Reducing Readmissions. Catholic Medical Center July 27, 2012. Highlights. Data Lean Six Sigma Improvement Initiative QIO Improvement Initiative AMI, HF, Pneumonia Readmission Strategies Key Strategies Catholic Medical Center. CMC - US Readmission Rates 2007-2010. CMS Hospital Compare.

270 views • 11 slides

Total Occlusion Study of Canada (TOSCA-2) Trial

TOSCA-2 Trial. Total Occlusion Study of Canada (TOSCA-2) Trial. Presented at The American Heart Association Scientific Sessions 2006 Presented by Dr. Vladimir Dzavik. TOSCA-2 Trial: Background.

369 views • 9 slides

Effect of Distal Embolisation on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quant

Effect of Distal Embolisation on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quantitative MR Perfusion Study. Selvanayagam JB MBBS, DPhil ; Cheng ASH MBBS ; Jerosch-Herold M PhD ; Rahimi K MD ;Porto I MD ; Neubauer S MD ; Banning AP MD.

226 views • 9 slides

Randomized, double-blind active-control 10,462 high CV-risk hypertensive patients age 55+ yrs

Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH): Design. Randomized, double-blind active-control 10,462 high CV-risk hypertensive patients age 55+ yrs No history of symptomatic HF or evidence of LVEF<40%

147 views • 3 slides